Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-03-04 @ 1:36 PM
Study NCT ID:
NCT01228760
Status:
COMPLETED
Last Update Posted:
2013-06-07
First Post:
2010-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-21
First Submit QC Date:
None
Study First Post Date:
2010-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-06
Last Update Post Date:
2013-06-07
Last Update Post Date Type:
ESTIMATED